Literature DB >> 12112076

Periaxin mutations cause a broad spectrum of demyelinating neuropathies.

Hiroshi Takashima1, Cornelius F Boerkoel, Peter De Jonghe, Chantal Ceuterick, Jean-Jacques Martin, Thomas Voit, J-Michael Schröder, Anna Williams, Peter J Brophy, Vincent Timmerman, James R Lupski.   

Abstract

Previous studies have demonstrated that apparent loss-of-function mutations in the periaxin gene cause autosomal recessive Dejerine-Sottas neuropathy or severe demyelinating Charcot-Marie-Tooth disease. In this report, we extend the associated phenotypes with the identification of two additional families with novel periaxin gene mutations (C715X and R82fsX96) and provide detailed neuropathology. Each patient had marked sensory involvement; two siblings with a homozygous C715X mutation had much worse sensory impairment than motor impairment. Despite early disease onset, these siblings with the C715X mutation had relatively slow disease progression and adult motor impairment typical of classic demyelinating Charcot-Marie-Tooth neuropathy. In contrast, a patient with the homozygous R82fsX96 mutation had a disease course consistent with Dejerine-Sottas neuropathy. The neuropathology of patients in both families was remarkable for demyelination, onion bulb and occasional tomacula formation with focal myelin thickening, abnormalities of the paranodal myelin loops, and focal absence of paranodal septate-like junctions between the terminal loops and axon. Our study indicates a prominent sensory neuropathy resulting from periaxin gene mutations and suggests a role for the carboxyl terminal domain of the periaxin protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112076     DOI: 10.1002/ana.10213

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  31 in total

Review 1.  Neuropathology of Charcot-Marie-Tooth and related disorders.

Authors:  J Michael Schröder
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Philipp Berger; Ueli Suter
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Periaxin mutation in Japanese patients with Charcot-Marie-Tooth disease.

Authors:  Tesshu Otagiri; Kenji Sugai; Kazuki Kijima; Hiroko Arai; Yukio Sawaishi; Mitsuteru Shimohata; Kiyoshi Hayasaka
Journal:  J Hum Genet       Date:  2006-06-13       Impact factor: 3.172

Review 4.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 5.  Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease.

Authors:  O Dubourg; H Azzedine; C Verny; G Durosier; N Birouk; R Gouider; M Salih; A Bouhouche; A Thiam; D Grid; M Mayer; M Ruberg; M Tazir; A Brice; E LeGuern
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  Late-onset Charcot-Marie-Tooth disease 4F caused by periaxin gene mutation.

Authors:  Shoko Tokunaga; Akihiro Hashiguchi; Akiko Yoshimura; Kengo Maeda; Takashi Suzuki; Hiroyo Haruki; Tomonori Nakamura; Yuji Okamoto; Hiroshi Takashima
Journal:  Neurogenetics       Date:  2012-08-01       Impact factor: 2.660

7.  Remodeling of motor nerve terminals in demyelinating axons of periaxin-null mice.

Authors:  Felipe A Court; Peter J Brophy; Richard R Ribchester
Journal:  Glia       Date:  2008-03       Impact factor: 7.452

8.  Autosomal recessive forms of Charcot-Marie-Tooth disease.

Authors:  J M Vallat; D Grid; C Magdelaine; F Sturtz; M Tazir
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

Review 9.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15

10.  Periaxin mutation causes early-onset but slow-progressive Charcot-Marie-Tooth disease.

Authors:  Kazuki Kijima; Chikahiko Numakura; Emi Shirahata; Yukio Sawaishi; Mitsuteru Shimohata; Shuichi Igarashi; Tomohiro Tanaka; Kiyoshi Hayasaka
Journal:  J Hum Genet       Date:  2004-06-12       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.